Morgan D. Elwyn

Partner

New York
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, NY 10019-6099
T 212 728 8981
F 212 728 9981
melwynwillkie.com

Morgan Elwyn is a partner in the Corporate & Financial Services Department. Morgan’s practice includes mergers and acquisitions, joint ventures, private equity transactions and capital market transactions. In the private equity area, Morgan’s practice include early stage and growth equity investments, mergers and acquisitions as well as portfolio company representation, with an emphasis on software and technology companies.

Highlights

Morgan Elwyn is a partner in the Corporate & Financial Services Department. Morgan’s practice includes mergers and acquisitions, joint ventures, private equity transactions and capital market transactions. In the private equity area, Morgan’s practice include early stage and growth equity investments, mergers and acquisitions as well as portfolio company representation, with an emphasis on software and technology companies.

Selected Significant Matters

Morgan’s experience includes the following representations:

  • New Mountain Capital in its acquisition of DRB Holdings
  • New Mountain Capital in its acquisition of Sparta Systems, Inc. from Thoma Bravo, LLC 
  • Kinnser Software and Insight Venture Partners in the sale of Kinnser to Mediware Information Systems
  • SmartBear Software in its acquisition by Francisco Partners
  • Insight Venture Partners in its acquisition of Zyme Solutions
  • Valtech Cardio in its acquisition by Edwards Lifesciences Corporation for up to $690 million
  • LOGICnow in its acquisition by SolarWinds
  • Warburg Pincus and the Association of Certified Anti-Money Laundering Specialists (ACAMS) in the $330 million sale of ACAMS to Becker Professional Education
  • Insight Venture Partners in its acquisition of Diligent, a take-private transaction valued at approximately $624 million
  • MedAssets in its acquisition by Pamplona Capital Management for $2.7 billion
  • Syncsort in its acquisition by Clearlake Capital Group
  • Valtech Cardio in its proposed acquisition by HeartWare International for $875 million
  • Insight Venture Partners in its acquisition of Thycotic
  • Appriss in its acquisition of The Retail Equation
  • Insight Venture Partners in its acquisition of Fourth
  • HealthcareSource in its acquisition by Francisco Partners
  • Insight Venture Partners in its take-private acquisition of E2open
  • AdColony in its acquisition by Opera
  • MedAssets, Inc. in its acquisition of Sg-2, LLC.
  • GFI Software in the sale of TeamViewer to Permira
  • Insight Venture Partners in its leveraged acquisition of WorkForce Software
  • Insight Venture Partners and its portfolio company ECi Software Solutions in the sale of ECi to The Carlyle Group
  • Insight Venture Partners in its significant investment in Kaseya
  • Insight Venture Partners in the $6.9 billion consortium acquisition of BMC Software
  • Insight Venture Partners in the $2 billion buyout agreement to take Quest Software private
  • Insight Venture Partners as lead investor in the $165 million equity financing of Drilling Info, Inc., acquiring majority ownership of the company
  • Teva Pharmaceutical Industries Limited in its consumer health care joint venture with The Procter & Gamble Company
  • MedAssets, Inc. in connection with its acquisition of The Broadlane Group
  • MedAssets, Inc. in connection with its acquisition of Accuro Healthcare Solutions, Inc.
  • Insight Venture Partners and Lightyear Capital Partners in the acquisition of Realm Business Solutions and subsequent disposition to Altus Group Limited
  • Cablevision Special Committee in connection with the spin-off of the Madison Square Garden business and regarding proposed going private transactions with the Dolan family
  • MedAssets, Inc. in connection with its initial public offering of common stock
  • Eagle Family Foods, Inc. in connection with its sale to The J.M. Smucker Company